1. Tepper ML, Gully PR. Viral hepatitis: know your D, E, F, and G. Can Med Assoc J. 1997;156:1735-1738.

2. Bhattarai N, Stapleton, JT. GB virus C: the good boy virus? Trends Microbiol. 2012;20(3):124-130.

3. Bickley LS. Bates' Guide to Physical Examination and History Taking. 12th ed. Philadelphia, PA: Lippincott; 2016.

4. Hall JE (ed). Guyton and Hall Textbook of Medical Physiology. 14th ed. Philadelphia, PA: Saunders; 2020.

5. Murali AR, Carey WD. Common Tests for Liver Disease. Available at https://my.clevelandclinic.org/departments/digestive/medical-professionals/hepatology/liver-tests. Last accessed January 17, 2024.

6. Nabili ST. Liver Blood Tests. Available at https://www.emedicinehealth.com/liver_blood_tests/article_em.htm. Last accessed January 17, 2024.

7. MedlinePlus. ALP Isoenzyme Test. Available at https://medlineplus.gov/ency/article/003497.htm. Last accessed January 17, 2024.

8. Bennett JE, Dolin R, Blaser MJ (eds). Mandell, Douglas and Bennett's Infectious Disease Essentials. 1st ed. Philadelphia, PA: Elsevier; 2016.

9. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Washington, DC: Public Health Foundation; 2015.

10. Goldsmith C. Hepatitis. Minneapolis, MN: Twenty-First Century Books; 2011.

11. Centers for Disease Control and Prevention. Disease Burden from Hepatitis A, B, and C in the United States. Available at https://www.cdc.gov/hepatitis/PDFs/disease_burden.pdf. Last accessed January 17, 2024.

12. U.S. Department of Health and Human Services. Viral Hepatitis National Strategic Plan Overview. Available at https://www.hhs.gov/hepatitis/viral-hepatitis-national-strategic-plan/national-viral-hepatitis-action-plan-overview/index.html. Last accessed January 17, 2024.

13. World Health Organization. Hepatitis A. Available at https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/hep-a#. Last accessed January 17, 2024.

14. Lin YN, Chou JW, Cheng KS, Peng CY, Jeng LB, Chiang IP. Treatment of fulminant autoimmune hepatitis: corticosteroid therapy or liver transplantation? A case report and literature review. Gastroenterology Res. 2011;4(5):231-235.

15. Redfield RR, Schuchat A, Richards CL, et al. Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR. 2020;69(5):1-38.

16. LexiComp Online. Available at https://online.lexi.com/action/login. Last accessed January 17, 2024.

17. Technical Bulletin: PURELL Healthcare Surface Disinfectant. Available at https://cdn2.hubspot.net/hubfs/43298/PURELL%20Healthcare%20Surface%20Disinfectant%20Technical%20Bulletin.pdf . Last accessed January 17, 2024.

18. Samji NS. Viral Hepatitis. Available at https://emedicine.medscape.com/article/775507-overview. Last accessed January 17, 2024.

19. Cassity S. Hepatitis in Pregnancy. Available at https://emedicine.medscape.com/article/1562368-overview. Last accessed January 17, 2024.

20. World Health Organization. Hepatitis E. Available at https://www.who.int/news-room/fact-sheets/detail/hepatitis-e. Last accessed January 17, 2024.

21. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology. 2018;67(4):1560-1599.

22. Thio CL, Hawkins C. Hepatitis B virus and hepatitis delta virus. In: Bennett JE, Dolin R, Blaser MJ (eds). Mandell, Douglas and Bennett's Infectious Disease Essentials. 1st ed. Philadelphia, PA: Elsevier; 2016: 198-201.

23. Centers for Disease Control and Prevention. Hepatitis B Information. Frequently Asked Questions for Health Professionals. Available at https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm. Last accessed January 17, 2024.

24. Illinois Department of Public Health. Hepatitis B. Available at http://www.idph.state.il.us/public/hb/hbhepb.htm. Last accessed January 17, 2024.

25. Luu L. Liver Transplants. Available at https://emedicine.medscape.com/article/776313-overview. Last accessed January 17, 2024.

26. Gewirtzman A, Bobrick L, Conner K, Tyring SK. Epidemiology of sexually transmitted infections. In: Gross G, Tyring SK (eds). Sexually Transmitted Infections and Sexually Transmitted Diseases. Berlin: Springer; 2011.

27. Centers for Disease Control and Prevention. Viral Hepatitis Serology Training. Available at https://www.cdc.gov/hepatitis/resources/professionals/training/serology/training.htm. Last accessed January 17, 2024.

28. Abbott Diagnostics. Hepatitis Learning Guide. Abbott Park, IL: Abbott Diagnostics Educational Services; 1999.

29. Centers for Disease Control and Prevention. Hepatitis B Information. Interpretation of Hepatitis B Serologic Test Results. Available at https://www.cdc.gov/hepatitis/hbv/interpretationOfHepBSerologicResults.htm. Last accessed January 17, 2024.

30. Sood GK. Acute Liver Failure. Available at https://emedicine.medscape.com/article/177354-overview. Last accessed January 17, 2024.

31. The Hepatitis Trust. Risks and Causes. Available at https://www.hepctrust.org.uk/about-hep-c/risks-and-causes/. Last accessed January 17, 2024.

32. Sherman M. Management of viral hepatitis: clinical and public health perspectives—a consensus statement. Can J Gastroenterol. 1997;11(5):407-416.

33. Lim SG, Ng TM, Kung N, et al. A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B. Arch Intern Med. 2006;166(1):49-56.

34. Paul N, Han SH. Combination therapy for chronic hepatitis B: current indications. Curr Hepat Rep. 2011;10(2):98-105.

35. Soriano V, Barreiro P, Cachay E, et al. Advances in hepatitis B therapeutics. Ther Adv Infectious Dis. 2020;7:1-11.

36. U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Available at https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf. Last accessed January 17, 2024.

37. U.S. Food and Drug Administration. BLA Approval Letter. Available at https://www.fda.gov/media/108828/download?attachment. Last accessed January 17, 2024.

38. Centers for Disease Control and Prevention. ACIP Presentation Slides: November 2-3, 2021 Meeting. Available at https://www.cdc.gov/vaccines/acip/meetings/slides-2021-11-2-3.html. Last accessed January 17, 2024.

39. Centers for Disease Control and Prevention. Hepatitis B Vaccination of Infants, Children, and Adolescents. Available at https://www.cdc.gov/hepatitis/hbv/vaccchildren.htm. last accessed January 17, 2024.

40. Evans AA, Cohen C, Block TM. Hepatitis viruses: hepatitis B and hepatitis D. In: Kaslow RA, Stanberry LR, LeDuc JW (eds). Viral Infections of Humans: Epidemiology and Control. 5th ed. New York, NY: Springer; 2014: 747-764.

41. World Health Organization. Hepatitis B. Available at https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Last accessed January 17, 2024.

42. Samji NS. Viral Hepatitis Clinical Presentation. Available at https://emedicine.medscape.com/article/775507-clinical. Last accessed January 17, 2024.

43. Wedemyer H, Yurdaydìn C, Dalekos GN, et al. Peginterferon plus adefovir versus drug alone for hepatitis delta. N Engl J Med. 2011;364(4):322-331.

44. Dienstag JL, Delemos AS. Viral hepatitis. In: Bennett JE, Dolin R, Blaser MJ (eds). Mandell, Douglas and Bennett's Infectious Disease Essentials. 1st ed. Philadelphia, PA: Elsevier; 2016: 130-137.

45. Centers for Disease Control and Prevention. Hepatitis C Questions and Answers for Health Professionals. Available at https://www.cdc.gov/hepatitis/HCV/HCVfaq.htm. Last accessed January 17, 2024.

46. Hedskog C, Parhy B, Chang S, et al. Identification of 19 novel hepatitis C virus subtypes: further expanding HCV classification. Open Forum Infect Dis. 2019;6(3):ofz076.

47. Cox R. Hepatitis C (Hep C, HCV). Available at https://www.emedicinehealth.com/hepatitis_c/article_em.htm. Last accessed January 17, 2024.

48. Strader DB. Coinfection with HIV and hepatitis C virus in injection drug users and minority populations. Clin Infect Dis. 2005;41(1):S7-S13.

49. Centers for Disease Control and Prevention. Hepatitis C Surveillance 2021: Hepatitis C Figures and Tables. Available at https://www.cdc.gov/hepatitis/statistics/2021surveillance/hepatitis-c.htm#anchor_03753. Last accessed January 17, 2024.

50. Dhawan VK. Hepatitis C. Available at https://emedicine.medscape.com/article/177792-overview. Last accessed January 17, 2024.

51. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156(4):271-278.

52. Centers for Disease Control and Prevention. Hepatitis C Mortality. Available at https://www.cdc.gov/nchhstp/newsroom/2016/hcv-mortality.html Last accessed January 17, 2024.

53. Centers for Disease Control and Prevention. Hepatitis C Kills More Americans than Any Other Infectious Disease. Available at https://www.cdc.gov/nchhstp/newsroom/2016/hcv-press-release.html. Last accessed January 17, 2024.

54. Wester C, Osinubi A, Kaufman HW, et al. Hepatitis C virus clearance cascade – United States, 2013-2022. MMWR. 2023;72(26):716-720.

55. U.S. Preventive Services Task Force. Screening for hepatitis C virus infection in adolescents and adults: U.S. Preventive Services Task Force recommendation statement. JAMA. 2020;323(10):970-975.

56. Centers for Disease Control and Prevention. CDC Urging Dialysis Providers and Facilities to Assess and Improve Infection Control Practices to Stop Hepatitis C Virus Transmission in Patients Undergoing Hemodialysis. Available at https://emergency.cdc.gov/han/han00386.asp. Last accessed January 17, 2024.

57. Benova L, Mohamoud YA, Calvert C, et al. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis. 2014;59(6):765-73.

58. Bennett NJ. Pediatric Hepatitis C Clinical Presentation. Available at https://emedicine.medscape.com/article/964761-clinical. Last accessed January 17, 2024.

59. Alberti A, Benvegnù L. Viral infections of the liver. In: Rodés J, Benhamou JP, Blei A, REichen J, Rizzetto M(eds). Textbook of Hepatology: From Basic Science to Clinical Practice. 3rd ed. Oxford: Blackwell Publishing; 2007.

60. Poynard T, Bedossa P, Opolon, P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 1997;349(9055):825-832.

61. Lab Tests Online. Hepatitis C Test. Available at https://www.testing.com/tests/hepatitis-c-test/. Last accessed January 17, 2024.

62. Kohli A, Shaffer A, Sherman A, Kottilil S. Treatment of hepatitis C: a systematic review. JAMA. 2014;312(6):631-640.

63. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. 1998;47(RR19):1-39.

64. The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. Available at https://www.hcvguidelines.org/sites/default/files/full-guidance-pdf/AASLD-IDSA_HCVGuidance_December_19_2023.pdf.6 Accessed January 17, 2024.

65. Bhattacharya D, Aronsohn A, Price J, Lo Re V III. Hepatitis C guidance 2023 update: American Association for the Study of Liver Diseases – Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection. Clin Infect Dis. [ePub ahead of print].

66. Manns MP, Pockros PJ, Norkrans G, et al. Long-term clearance of hepatitis C virus following interferon alpha-2b or peginterferon alpha-2b, alone or in combination with ribavirin. J Viral Hepat. 2013;20(8):524-529.

67. Martin P. Update on Hepatitis C Treatment. Available at https://www.medscape.com/viewarticle/407963?&icd=login_success_email_match_fpf. Last accessed January 17, 2024.

68. U.S. Department of Veterans Affairs. Chronic Hepatitis C Virus (HCV) Infection: Treatment Considerations. Available at https://www.hepatitis.va.gov/hcv/treatment/hcv-treatment-considerations.asp. Last accessed January 17, 2024.

69. National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2012.

70. U.S. Food and Drug Administration. [FDA News Release: Archive]. FDA Approves Technivie for Treatment of Chronic Hepatitis C Genotype 4. Available at https://wayback.archive-it.org/7993/20170112222743/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm455857.htm. Last accessed January 17, 2024.

71. U.S. Food and Drug Administration. FDA Approves New Treatment for Pediatric Patients with Any Strain of Hepatitis C. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-pediatric-patients-any-strain-hepatitis-c. Last accessed January 17, 2024.

72. U.S. Food and Drug Administration. FDA Approves Mavyret for Hepatitis C. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-mavyret-hepatitis-c. Last accessed January 17, 2024.

73. Petta S, Craxi A. Current and future HCV therapy: do we still need other anti-HCV drugs? Liver Internat. 2015;35:4-10.

74. Hoofnagle J, Sherker A. Therapy for hepatitis C: the cost of success. N Engl J Med. 2014;370:1552-1553.

75. Nemergut K, Littlewood EC. Liver diseases. In: Fleisher LA (ed). Anesthesia and Uncommon Diseases. 6th ed. Philadelphia, PA: Saunders, 2012; 151-202.

76. American Liver Foundation. Liver Transplant. Available at https://liverfoundation.org/liver-diseases/treatment/liver-transplant/. Last accessed January 17, 2024.

77. Chung RT, Dienstag JL. Liver transplantation. In: Fauci AS, Braunwals E, Isselbacher K, Wilson J, Martin J, Kasper DL, Hauser SL, Longo D (eds). Harrison's Principles of Internal Medicine. 19th ed. New York, NY: McGraw-Hill; 2015.

78. Kwong AJ, Ebel NH, Kim WR, et al. OPTN/SRTR 2020 annual data report: liver. Am J Transplant. 2022;(Suppl 2):204-309.

79. Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol. 2011;54(6):1297-1306.

80. Lucey MR. New Trends in Liver Transplantation. Conference Summary, the American Association for the Study of Liver Diseases 50th Annual Meeting. Dallas, TX. November 5–9, 1999.

81. Chan C, Fan ST, Lo CM, et al. A decade of right liver adult-to-adult living donor liver transplantation: the recipient mid-term outcomes. Ann Surg. 2008:248(3):411-419.

82. Organ Procurement and Transplantation Network. New National Liver and Intestinal Organ Transplant System in Effect. Available at https://optn.transplant.hrsa.gov/news/new-national-liver-and-intestinal-organ-transplant-system-in-effect/. Last accessed January 17, 2024.

83. Rosen HR, Martin P. Hepatitis B and C in the liver transplant recipient. Semin Liver Dis. 2000;20:465-480.

84. Hanto DW. A 50-year-old man with hepatitis C and cirrhosis needing liver transplantation. JAMA. 2003;290(24):3238-3246.

85. Merck Manual Professional Version. Liver Transplantation. Available at https://www.merckmanuals.com/professional/immunology-allergic-disorders/transplantation/liver-transplantation. Last accessed January 17, 2024.

86. Conners EE, Panagiotakopoulos L, Hofmeister MG, et al. Screening and testing for hepatitis B virus infection: CDC recommendations—United States, 2023. MMWR. 2023;72(1):1-25.

87. Panagiotakopoulos L, Sandul AL, Conners EE, Foster MA, Nelson NP, Wester C. CDC recommendations for hepatitis C testing among perinatally exposed infants and children—United States, 2023. MMWR. 2023;72(4):1-19.